L8B Stock Overview

A medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. More details

L8B fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	2/6
Financial Health	6/6
Dividends	5/6

Rewards

Trading at 36% below our estimate of its fair value

Earnings are forecast to grow 8.74% per year

Pays a reliable dividend of 3.34%

Risk Analysis

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Japan Lifeline Co., Ltd. Competitors

Drägerwerk KGaA

XTRA:DRW3

€947.2m

Stratec

XTRA:SBS

€381.7m

Eckert & Ziegler

XTRA:EUZ

€1.3b

PULSION Medical Systems

MUN:PUS

€136.0m

Price History & Performance

Summary of share price highs, lows and changes for Japan Lifeline
Historical stock prices
Current Share Price	JP¥9.78
52 Week High	JP¥9.93
52 Week Low	JP¥9.71
Beta	0.12
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-1.56%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	L8B	DE Medical Equipment	DE Market
7D	-0.4%	-1.5%	3.0%
1Y	n/a	-2.6%	19.3%

Return vs Industry: Insufficient data to determine how L8B performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how L8B performed against the German Market.

Price Volatility

Is L8B's price volatile compared to industry and market?
L8B volatility
L8B Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.8%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.4%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: L8B's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine L8B's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1981	1,216	Keisuke Suzuki	www.japanlifeline.com

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters.

Japan Lifeline Co., Ltd. Fundamentals Summary

How do Japan Lifeline's earnings and revenue compare to its market cap?
L8B fundamental statistics
Market cap	€705.60m
Earnings (TTM)	€53.29m
Revenue (TTM)	€354.06m

13.2x

P/E Ratio

2.0x

P/S Ratio

Is L8B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
L8B income statement (TTM)
Revenue	JP¥55.89b
Cost of Revenue	JP¥22.30b
Gross Profit	JP¥33.59b
Other Expenses	JP¥25.18b
Earnings	JP¥8.41b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	120.02
Gross Margin	60.10%
Net Profit Margin	15.05%
Debt/Equity Ratio	6.4%

How did L8B perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

36%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 21:44
End of Day Share Price	2025/02/19 00:00
Earnings	2024/12/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Japan Lifeline Co., Ltd. is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yang Luo	CLSA
Steven Liu	CLSA
null null	Company Forecast